Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Countries and organisations
Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.
Free access · No subscription for research tools or data exports
Explore registry geography and organisations
5 trials match this view; 4 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 432 across 5 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility TrialPersisting Symptoms After Concussion | University of Calgary PHASE1 | Recruiting Registry updated 2026-09-09 | 40 ESTIMATED | 2025-05-27 2027-06-30 2027-12-30 | |
| Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner ViolencePost Traumatic Stress Disorder PTSD · Intimate Partner Violence (IPV) | University of Calgary PHASE2 | Not yet recruiting Registry updated 2026-09-08 | 76 ESTIMATED | 2026-10-01 2028-08-01 2029-08-01 | |
| High vs. Low-Dose Group-Based Psilocybin-Assisted Therapy (PAT) With or Without Mindfulness-Based (MB) Preparation and Integration for Demoralization in Adults With Advanced Cancer (PAT-MIND): A Pilot Feasibility 2x2 Factorial Multisite TrialAdvanced Cancer · Demoralization · Existential Distress · Psychological Distress | University of Calgary PHASE2 | Not yet recruiting Registry updated 2026-09-02 | 60 ESTIMATED | 2026-10-30 2027-12-20 2027-12-31 | |
| The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsInvestigating the Importance of the Subjective Psychedelic Experience | University of Calgary PHASE2 | Recruiting Registry updated 2026-09-02 | 128 ESTIMATED | 2026-05-15 2027-12 2028-01 | |
| Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical TrialAlcohol Use Disorder · Alcoholism | University of Calgary PHASE2 | Recruiting Registry updated 2024-05-07 | 128 ESTIMATED | 2024-03-20 2027-10-01 2027-10-01 |
Reported research facilities
University of CalgaryCalgary, Alberta, Canada
The University of British Columbia - Okanagan CampusKelowna, British Columbia, Canada
Arthur Child Comprehensive Cancer CentreCalgary, Alberta, Canada
Providence Care HospitalKingston, Ontario, Canada
This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.